Literature DB >> 19639307

Differential expression of receptor protein tyrosine phosphatases accompanies the reorganisation of the retina upon laser lesion.

Manuela Besser1, Andrea Horvat-Bröcker, Ulf T Eysel, Andreas Faissner.   

Abstract

The regulation of protein phosphorylation plays an essential role in virtually all aspects of eukaryotic development. Beginning with the regulation of the cell cycle to cellular proliferation and differentiation, the delicate balance between the phosphorylating activity of kinases and the dephosphorylation by phosphatases controls the outcome of many signal transduction cascades. The generation of cellular diversity occurs in an environment that is structured by the extracellular matrix (ECM) which forms a surrounding niche for stem and progenitor cells. Cell-cell and cell-matrix interactions elicit specific signaling pathways that control cellular behavior. In pathological situations such as neural degenerating diseases, gene expression patterns and finally the composition of the ECM change dramatically. This leads to changes of cell behavior and finally results in the failure of regeneration and functional restoration in the adult central nervous system. In order to study the roles of tyrosine phosphatases and ECM in this context, we analyzed the effects of laser-induced retinal injury on the regulation of the receptor protein tyrosine phosphatases (RPTP) RPTPBr7, Phogrin and RPTPbeta/zeta. The latter occurs in several isoforms, including the soluble released chondroitin sulfate proteoglycan phosphacan that is expressed in the developing retina. The receptor variants RPTPbeta/zeta(long) and RPTPbeta/zeta(short) may serve as receptors of tenascin-proteins and serve as modulators of cell intrinsic signaling in response to the ECM. Using quantitative real-time RT-PCR analysis, we show here a time-dependent pattern of gene expression of these molecules following laser lesions of the retina.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19639307     DOI: 10.1007/s00221-009-1932-0

Source DB:  PubMed          Journal:  Exp Brain Res        ISSN: 0014-4819            Impact factor:   1.972


  53 in total

1.  Assignment1 of the PTP-SL/PTPBR7 gene (Ptprr/PTPRR) to mouse chromosome region 8A2 by in situ hybridization.

Authors:  A M van den Maagdenberg; J T Schepens; M T Schepens; G F Merkx; F Darroudi; B Wieringa; A Geurts van Kessel; W J Hendriks
Journal:  Cytogenet Cell Genet       Date:  1999

2.  Role of cytokines in lipopolysaccharide-induced functional and structural abnormalities of astrocytes.

Authors:  S Hu; A Martella; W R Anderson; C C Chao
Journal:  Glia       Date:  1994-03       Impact factor: 7.452

3.  Phosphacan short isoform, a novel non-proteoglycan variant of phosphacan/receptor protein tyrosine phosphatase-beta, interacts with neuronal receptors and promotes neurite outgrowth.

Authors:  Jeremy Garwood; Nicolas Heck; Frank Reichardt; Andreas Faissner
Journal:  J Biol Chem       Date:  2003-04-16       Impact factor: 5.157

Review 4.  DSD-1-Proteoglycan/Phosphacan and receptor protein tyrosine phosphatase-beta isoforms during development and regeneration of neural tissues.

Authors:  Andreas Faissner; Nicolas Heck; Alexandre Dobbertin; Jeremy Garwood
Journal:  Adv Exp Med Biol       Date:  2006       Impact factor: 2.622

5.  Effects of synthetic progestagens on the mRNA expression of androgen receptor, progesterone receptor, oestrogen receptor alpha and beta, insulin-like growth factor-1 (IGF-1) and IGF-1 receptor in heifer tissues.

Authors:  M W Pfaffl; A Daxenberger; M Hageleit; H H D Meyer
Journal:  J Vet Med A Physiol Pathol Clin Med       Date:  2002-03

6.  Differential expression of phosphacan/RPTPbeta isoforms in the developing mouse visual system.

Authors:  Alice Klausmeyer; Jeremy Garwood; Andreas Faissner
Journal:  J Comp Neurol       Date:  2007-10-20       Impact factor: 3.215

7.  Anaplastic lymphoma kinase is activated through the pleiotrophin/receptor protein-tyrosine phosphatase beta/zeta signaling pathway: an alternative mechanism of receptor tyrosine kinase activation.

Authors:  Pablo Perez-Pinera; Wei Zhang; Yunchao Chang; Jose Antonio Vega; Thomas F Deuel
Journal:  J Biol Chem       Date:  2007-08-06       Impact factor: 5.157

8.  Receptor protein tyrosine phosphatases are expressed by cycling retinal progenitor cells and involved in neuronal development of mouse retina.

Authors:  A Horvat-Bröcker; J Reinhard; S Illes; T Paech; G Zoidl; S Harroch; C Distler; P Knyazev; A Ullrich; A Faissner
Journal:  Neuroscience       Date:  2008-01-25       Impact factor: 3.590

9.  Regulation of RPTPbeta/phosphacan expression and glycosaminoglycan epitopes in injured brain and cytokine-treated glia.

Authors:  Alexandre Dobbertin; Kate E Rhodes; Jeremy Garwood; Francesca Properzi; Nicolas Heck; John H Rogers; James W Fawcett; Andreas Faissner
Journal:  Mol Cell Neurosci       Date:  2003-12       Impact factor: 4.314

10.  Involvement of receptor-like protein tyrosine phosphatase zeta/RPTPbeta and its ligand pleiotrophin/heparin-binding growth-associated molecule (HB-GAM) in neuronal migration.

Authors:  N Maeda; M Noda
Journal:  J Cell Biol       Date:  1998-07-13       Impact factor: 10.539

View more
  3 in total

Review 1.  Influence of the extracellular matrix on endogenous and transplanted stem cells after brain damage.

Authors:  Lars Roll; Andreas Faissner
Journal:  Front Cell Neurosci       Date:  2014-08-19       Impact factor: 5.505

Review 2.  Tenascins in Retinal and Optic Nerve Neurodegeneration.

Authors:  Jacqueline Reinhard; Lars Roll; Andreas Faissner
Journal:  Front Integr Neurosci       Date:  2017-10-23

3.  Early remodelling of the extracellular matrix proteins tenascin-C and phosphacan in retina and optic nerve of an experimental autoimmune glaucoma model.

Authors:  Sabrina Reinehr; Jacqueline Reinhard; Susanne Wiemann; Gesa Stute; Sandra Kuehn; Julia Woestmann; H Burkhard Dick; Andreas Faissner; Stephanie C Joachim
Journal:  J Cell Mol Med       Date:  2016-07-04       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.